Medical device licence · 10121 · Class 3
EBV EARLY ANTIGEN IFA
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed August 18, 1999; ended October 14, 2016. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 10121
- Licence holder
- Diasorin Molecular LlcCypress, CA, United States
- Risk class
- Class III (moderate to high risk)
- Licence type
- Test Kit
- First licensed
- August 18, 1999
- Ended
- October 14, 2016
- Devices covered
- 1
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- EBV EARLY ANTIGEN IFA
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.